Organogenesis Holdings Inc.
ORGO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $482 | $433 | $451 | $467 |
| % Growth | 11.3% | -3.9% | -3.5% | – |
| Cost of Goods Sold | $116 | $106 | $105 | $114 |
| Gross Profit | $366 | $327 | $346 | $353 |
| % Margin | 76% | 75.4% | 76.7% | 75.6% |
| R&D Expenses | $50 | $44 | $40 | $31 |
| G&A Expenses | $0 | $265 | $279 | $0 |
| SG&A Expenses | $295 | $270 | $284 | $250 |
| Sales & Mktg Exp. | $0 | $5 | $5 | $0 |
| Other Operating Expenses | $23 | $0 | $0 | $0 |
| Operating Expenses | $368 | $314 | $324 | $281 |
| Operating Income | -$1 | $13 | $22 | $72 |
| % Margin | -0.3% | 2.9% | 4.9% | 15.5% |
| Other Income/Exp. Net | -$2 | -$2 | -$2 | -$9 |
| Pre-Tax Income | -$3 | $10 | $20 | $63 |
| Tax Expense | -$4 | $5 | $5 | -$31 |
| Net Income | $1 | $5 | $16 | $94 |
| % Margin | 0.2% | 1.1% | 3.4% | 20.2% |
| EPS | 0.007 | 0.038 | 0.12 | 0.73 |
| % Growth | -82.8% | -68.6% | -83.6% | – |
| EPS Diluted | 0.007 | 0.037 | 0.12 | 0.7 |
| Weighted Avg Shares Out | 132 | 131 | 130 | 128 |
| Weighted Avg Shares Out Dil | 132 | 133 | 132 | 134 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $2 | $2 | $7 |
| Depreciation & Amortization | $17 | $23 | $18 | $17 |
| EBITDA | $16 | $36 | $40 | $87 |
| % Margin | 3.3% | 8.3% | 8.9% | 18.6% |